Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued
Go back to Ionis Pharmaceuticals (IONS) PT Lowered to $65 at RBC Capital After Tominersen Phase III Study was Discontinued| (NASDAQ: IONS) | Delayed: 40.15 -0.27 (0.67%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.42 | 52 Week High | $62.68 | |||
| Open | $41.38 | 52 Week Low | $19.59 | |||
| Day High | $41.53 | P/E | N/A | |||
| Day Low | $39.33 | EPS | $0.00 | |||
| Volume | 4,102,749 | |||||
| UNIQURE (NASDAQ: QURE) | Delayed: 23.03 -0.84 (3.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.87 | 52 Week High | $22.79 | |||
| Open | $24.10 | 52 Week Low | $6.63 | |||
| Day High | $24.22 | P/E | N/A | |||
| Day Low | $21.51 | EPS | $0.00 | |||
| Volume | 2,661,144 | |||||
| (NASDAQ: WVE) | Delayed: 3.62 +0.04 (1.12%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.58 | 52 Week High | $38.50 | |||
| Open | $3.70 | 52 Week Low | $8.95 | |||
| Day High | $3.78 | P/E | N/A | |||
| Day Low | $3.56 | EPS | $0.00 | |||
| Volume | 2,745,330 | |||||



